Stereotaxis Inc - ESG Rating & Company Profile powered by AI
This webpage of Stereotaxis Inc was prepared by All Street Sevva using cutting edge machine learning. Other corporations in the rating peer group for Stereotaxis Inc are shownin the table. The SDG rating for Stereotaxis Inc indicates its transparency towards the UN SDGs.
Stereotaxis Inc in the Advanced Medical Equipment & Technology industry gained a UN SDG ESG Transparency Score of 2.0; made up of an environmental score of 1.6, social score of 1.3 and governance score of 3.2.
2.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Calmark Sweden AB | 8.0 | High |
1 | CHC Healthcare Group | 8.0 | High |
... | ... | ... | |
208 | ProteinSimple | 2.2 | Medium |
216 | SciBase Holding AB (publ) | 2.1 | Medium |
217 | Stereotaxis Inc | 2.0 | Medium |
217 | Neovasc Inc | 2.0 | Medium |
217 | Surgical Science Sweden AB | 2.0 | Medium |
... | ... | ... | |
260 | Zhuhai Hokai Medical Instruments Co Ltd | 0.0 | Low |
260 | Zynex Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Stereotaxis Inc have an accelerator or VC vehicle to help deliver innovation?
Does Stereotaxis Inc disclose current and historical energy intensity?
Does Stereotaxis Inc report the average age of the workforce?
Does Stereotaxis Inc reference operational or capital allocation in relation to climate change?
Does Stereotaxis Inc disclose its ethnicity pay gap?
Does Stereotaxis Inc disclose cybersecurity risks?
Does Stereotaxis Inc offer flexible work?
Does Stereotaxis Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Stereotaxis Inc disclose the number of employees in R&D functions?
Does Stereotaxis Inc conduct supply chain audits?
Does Stereotaxis Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Stereotaxis Inc conduct 360 degree staff reviews?
Does Stereotaxis Inc disclose the individual responsible for D&I?
Does Stereotaxis Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Stereotaxis Inc disclose current and / or historical scope 2 emissions?
Does Stereotaxis Inc disclose water use targets?
Does Stereotaxis Inc have careers partnerships with academic institutions?
Did Stereotaxis Inc have a product recall in the last two years?
Does Stereotaxis Inc disclose incidents of discrimination?
Does Stereotaxis Inc allow for Work Councils/Collective Agreements to be formed?
Has Stereotaxis Inc issued a profit warning in the past 24 months?
Does Stereotaxis Inc disclose parental leave metrics?
Does Stereotaxis Inc disclose climate scenario or pathway analysis?
Does Stereotaxis Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Stereotaxis Inc disclose the pay ratio of women to men?
Does Stereotaxis Inc support suppliers with sustainability related research and development?
Does Stereotaxis Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Stereotaxis Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Stereotaxis Inc involved in embryonic stem cell research?
Does Stereotaxis Inc disclose GHG and Air Emissions intensity?
Does Stereotaxis Inc disclose its waste policy?
Does Stereotaxis Inc report according to TCFD requirements?
Does Stereotaxis Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Stereotaxis Inc disclose energy use targets?
Does Stereotaxis Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Stereotaxis Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Stereotaxis Inc
These potential risks are based on the size, segment and geographies of the company.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane full-power x-ray system, including c-arm, powered table, motorized boom, and large high-definition monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. Stereotaxis, Inc. markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to develop a magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri.